U.S. Gov. Whitmer reverses course on coronavirus drugs, is now asking feds for hydroxychloroquine and chloroquine

SOURCE: Metro Times, FDA

Gov. Gretchen Whitmer drew fire from some on the right after the Michigan Department of Licensing and Regulatory Affairs (LARA) sent a letter last week threatening “administrative action” against doctors who prescribed two experimental drugs that could potentially help coronavirus patients.

The Whitmer administration has since removed the language threatening doctors from the letter and is now asking the federal government to send shipments of the drugs, Bridge magazine reports. The Food and Drug Administration issued an emergency authorization for the antimalarial drugs hydroxychloroquine sulfate and chloroquine phosphate on Saturday.

RELATED Gov. Whitmer says she sees ‘great potential’ with coronovirus drug hydroxychloroquine; Detroit is now leading the nation’s first large-scale study

Conservatives, including Charlie Kirk and Rudy Giuliani, accused Whitmer of risking lives to oppose President Donald Trump. In recent weeks, Whitmer and Trump have been sparring on national television over federal aid for Michigan, while Trump has touted the drugs’ potential in treating COVID-19.

But apparently, Michigan’s “ban” on the drugs to treat coronavirus patients was all just a matter of miscommunication.

Days after LARA issued its first letter, The Detroit News published an op-ed that criticized the Whitmer administration’s prohibition of the drugs.

“Not only is our state’s top leader threatening the selfless health care workers who are on the frontline trying to save lives, but she’s denying possible life-saving medications to actual COVID-19 victims,” the op-ed said.

Some readers criticized the paper for irresponsibly advocating for untested drugs.

But Detroit News editor and publisher Gary Miles defended the column on Monday, pointing out that it revealed a miscommunication between the State Senate and the governor.

Senate Majority Leader Mike Shirkey, a Clarklake Republican, told The Detroit News that he asked the governor to issue the original letter to prevent people from hoarding the drugs and thus depriving non-coronavirus patients of their medicine.

“We needed something to prevent [chloroquine] from becoming the next toilet paper,” he told Miles. “I quickly requested of her staff that they put something out, and somehow in the translation it was prohibiting use of these drugs — and that wasn’t the intent.”

A close read of LARA’s original March 24 letter confirms the intent to make sure the drugs were being saved for non-coronavirus patients.

“Prescribing hydroxychloroquine or chloroquine without further proof of efficacy for treating COVID-19 or with the intent to stockpile the drug may create a shortage for patients with lupus, rheumatoid arthritis, or other ailments for which chloroquine and hydroxychloroquine are proven
treatments,” the letter reads. “… Again, these are drugs that have not been proven scientifically or medically to treat COVID-19.”

Shirkey told Miles he “was grateful for your article … because it was the first thing that alerted me that it was screwed up.”

On Monday, Whitmer said in a press conference that the state wants to be “nimble” and is always updating its policies.

“We want to ensure that doctors have the ability to prescribe these medicines,” she said. “We also want to make sure that the people who have prescriptions that predated COVID-19 have access to the medication they need. And so all of the work that we’ve done is trying to strike that balance.”

In its approval letter, the FDA wrote that “[b]ased on the totality of scientific evidence available to FDA, it is reasonable to believe that chloroquine phosphate and hydroxychloroquine sulfate may be effective in treating COVID-19.”

“When used under the conditions described in this authorization, the known and potential benefits of chloroquine phosphate and hydroxychloroquine sulfate when used to treat COVID-19 outweigh the known and potential risks of such products,” FDA Chief Scientist Denise M. Hinton wrote in the approval letter.

Whitmer also issued an executive order relaxing medical laws so personnel from out of state could help the state’s overloaded hospitals treat coronavirus patients. The executive order also offers doctors additional protections for medical errors.

“If you’re a health professional anywhere in America, Michigan needs you,” Whitmer said in a video posted to her Twitter. “Detroit, Michigan needs you especially.”

See the original here: https://www.metrotimes.com/news-hits/archives/2020/03/31/gov-whitmer-reverses-course-on-coronavirus-drugs-is-now-asking-feds-for-hydroxychloroquine-and-chloroquine

Official FDA letter to Dr Bright advising approval of hydroxychloroquine for use against Covid-19 here: https://www.fda.gov/media/136534/download

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »